A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Povetacicept in Adults With Immunoglobulin A Nephropathy (RAINIER)
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Povetacicept in Adults With Immunoglobulin A Nephropathy (RAINIER)
The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserving renal function.
Key Inclusion Criteria:
Key Exclusion Criteria:
Other protocol defined Inclusion/Exclusion criteria may apply.
San Francisco, California 94110, United States
Indianapolis, Indiana 46227, United States
Wels-Grieskirchen, Austria
Jinan, China
Shaanxi, China
Taian, China
Petah Tivka, Israel
Itabashi-ku, Japan
Kitakyushu-shi, Japan
Urayasu-shi, Japan
Lodzkie, Poland
Warsaw, Poland
Gangwon-do, South Korea
Gangwon-do, South Korea